Table 3. Selected molecular targets with potential therapeutic agents.
Gene | Drugs | References |
---|---|---|
EGFR | Cetuximab, erlotinib, gefitinib, afatinib, dacomitinib | (93) |
ERBB2 | Afatinib, dacomitinib, lapatinib | (93) |
N-cadherin | ADH-1 | (94) |
VEGFR1 | Vandetanib, sorafenib, sunitinib, axitinib, cabozantinib, pazopanib | (95) |
CX3CR1 | F1 hCX3CL1 analog | (96) |
MET | Onartuzumab, tivantinib | (93) |
CXCR4 | Plerixafor | (95) |